Cite
Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia.
MLA
Chizimu, Joseph Yamweka, et al. “Genomic Analysis of Mycobacterium Tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia.” Antibiotics (Basel, Switzerland), vol. 12, no. 7, June 2023. EBSCOhost, https://doi.org/10.3390/antibiotics12071126.
APA
Chizimu, J. Y., Solo, E. S., Bwalya, P., Kapalamula, T. F., Mwale, K. K., Squarre, D., Shawa, M., Lungu, P., Barnes, D. A., Yamba, K., Mufune, T., Chambaro, H., Kamboyi, H., Munyeme, M., Hang’ombe, B. M., Kapata, N., Mukonka, V., Chilengi, R., Thapa, J., … Suzuki, Y. (2023). Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia. Antibiotics (Basel, Switzerland), 12(7). https://doi.org/10.3390/antibiotics12071126
Chicago
Chizimu, Joseph Yamweka, Eddie Samuneti Solo, Precious Bwalya, Thoko Flav Kapalamula, Kaemba Kunkuta Mwale, David Squarre, Misheck Shawa, et al. 2023. “Genomic Analysis of Mycobacterium Tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia.” Antibiotics (Basel, Switzerland) 12 (7). doi:10.3390/antibiotics12071126.